Clinical trials
Terminated Phase 2/3 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| PTC Therapeutics | 3 |
| Pfizer | 3 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| Bristol-Myers Squibb | 2 |
| Gilead Sciences | 2 |
| Invivyd, Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 2 |
| Theravance Biopharma | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 5 |
| Colitis, Ulcerative | 4 |
| Inflammatory Bowel Diseases | 4 |
| Crohn Disease | 3 |
| Brain Injuries, Traumatic | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Squamous Cell | 2 |
| Drug Resistant Epilepsy | 2 |
| Hemiplegia | 2 |
| Leiomyosarcoma | 2 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.